Baclofen NDC 52536-600

NDC codes

FDA NDC Directory

Product NDC (as listed)52536-600Labeler and product segments. Claims need a package NDC.

Product NDC at billing width52536-0600Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
52536-600-11	52536060011	1 BOTTLE in 1 CARTON (52536-600-11) / 120 mL in 1 BOTTLEMarketed from Apr 1, 2023
52536-600-12	52536060012	1 BOTTLE in 1 CARTON (52536-600-12) / 300 mL in 1 BOTTLEMarketed from Apr 1, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Baclofen
Generic name (nonproprietary): baclofen
Active ingredients: Baclofen — 5 mg/mL
Dosage form: Suspension
Route: Oral
Labeler: Wilshire Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 215602
Marketing start: Apr 1, 2023
Listing expires: Dec 31, 2026
Other FDA classes: GABA A Agonists (Mechanism)GABA B Agonists (Mechanism)
Identifiers: Product ID 52536-600_461e14b2-890c-011c-e063-6294a90a0d4cSPL ID 461e14b2-890c-011c-e063-6294a90a0d4cSPL set ID 4585aafe-0af8-4786-a419-6a7e76671ca2RxCUI 2593376UNII H789N3FKE8
Pharmacologic class: gamma-Aminobutyric Acid-ergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N452536060011 followed by a unit qualifier and the quantity

Package 52536-0600-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 16, 2025.

Indications (excerpt from the label)

Baclofen is indicated for the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Baclofen may also be of some value in patients with spinal cord injuries and other spinal cord diseases. Limitations of Use Baclofen is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. Baclofen is a gamma-aminobutyric acid (GABA-ergic) agonist indicated for the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. ( 1 ) Baclofen may also be of some value in patient…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 215602

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 215602
Product	Strength	Form · route	Labeler	Product NDC
Fleqsuvybaclofen	Baclofen 5 mg/mL	SuspensionOral	Azurity Pharmaceuticals, Inc.	52652-6001